AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Metormi-G2 D Tablet SR

Prescription Icon
Prescription Required

Marketer

Serwina Pharmaceuticals Private Limited

Salt Composition

Glimepiride (2mg) + Metformin (1000mg)

Overview Metormi-G2 D Tablet SR

Diabeta-Duo SR tablets are a dual-action antidiabetic medication, combining two agents to manage type 2 diabetes in adults. This formulation effectively regulates blood glucose. Diabeta-Duo SR should be ingested with meals, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continued use is crucial, even with well-controlled blood sugar, as abrupt cessation can lead to dangerously elevated glucose levels, increasing the risk of kidney complications, vision impairment, neuropathy, and limb loss. This medication forms part of a comprehensive diabetes management plan, necessitating a healthy diet, regular physical activity, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a common side effect, characterized by symptoms like sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary snacks, fruit juice) are vital to mitigate this risk. Alcohol consumption should be limited due to its potential to exacerbate hypoglycemia. Additional potential side effects include altered taste perception, nausea, diarrhea, abdominal discomfort, cephalalgia, and upper respiratory infections. Weight gain may also occur. This medication is contraindicated in patients with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Individuals with a history of cardiovascular disease should inform their physician prior to commencing treatment. Consult your doctor before use during pregnancy or breastfeeding. Regular blood glucose monitoring and periodic blood tests (to assess blood cell counts and liver function) are recommended.

Uses of Metormi-G2 D Tablet SR

Managing type 2 diabetes

Major Benefits of Metormi-G2 D Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Metormi-G2 D Tablet SR whole; avoid chewing, crushing, or breaking it. This medication should be taken with food.

Common Side effects of Metormi-G2 D Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Metormi-G2 D Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for Metormi-G2 D Tablet SR. Ingest the tablet whole; do not crush, chew, or break it. Administer this medication with food.

How Metormi-G2 D Tablet SR works:

Metformin and Glimepiride, combined as Metormi-G2 D Tablet SR, offer a dual approach to diabetes management. Glimepiride, a sulfonylurea, stimulates the pancreas to release more insulin, thus reducing blood sugar levels. Metformin, a biguanide, acts through a threefold mechanism: decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol and Metormi-G2 D Tablet SR use poses a safety risk.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Metormi-G2 D Tablet SR during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Sustained-release Metormi-G2 tablets are contraindicated for breastfeeding mothers due to potential infant toxicity.

DrivingDrivingCAUTION

Driving may be impaired by excessively high or low blood sugar levels. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with impaired kidney function should use Metormi-G2 D Tablet SR cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates its use. Consult a physician. Regular kidney function monitoring is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Metormi-G2 D Tablet SR cautiously, potentially requiring dose modification. Consult a physician. A low initial dose is typically prescribed for those with mild to moderate liver disease; however, its use is contraindicated in patients with severe hepatic dysfunction.

What if you forget to take Metormi-G2 D Tablet SR :

Should you forget to take a Metormi-G2 D Tablet SR, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Metormi-G2 D Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Metormi-G2 D Tablet SR

Store this medication in its original, tightly closed container, as directed on the label or packaging. Discard any unused medication; keep it out of reach of children, pets, and others.
Metormi-G2 D Tablet SR can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA). This rare but potentially harmful side effect is more likely in patients with kidney disease, the elderly, or those who consume significant amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Metormi-G2 D Tablet SR and seek immediate medical attention.
Metormi-G2 D Tablet SR combines glimepiride and metformin to manage type 2 diabetes mellitus in adults. It enhances blood sugar control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and improves insulin sensitivity. This combination is unsuitable for type 1 diabetes.
Metormi-G2 D Tablet SR may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Prolonged Metormi-G2 D Tablet SR use can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left unaddressed, may result in anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and balance problems), urinary issues, and cognitive changes. To mitigate this risk, supplemental vitamin B12 is recommended at least annually by some researchers.
Metormi-G2 D Tablet SR can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Therefore, regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Metormi-G2 D Tablet SR and alcohol is unsafe. Alcohol can exacerbate the drug's blood sugar-lowering effects, potentially causing hypoglycemia and increasing the risk of lactic acidosis.
Metormi-G2 D Tablet SR
87
MRP 101
13% off